Literature DB >> 24460258

Risk factors for early recurrence of HBV-related hepatocellular carcinoma meeting milan criteria after curative resection.

Wen-Jiang Zhu1, Chu-Ying Huang, Chuan Li, Wei Peng, Tian-Fu Wen, Lv-Nan Yan, Bo Li, Wen-Tao Wang, Ming-Qing Xu, Jia-Yin Yang, Li Jiang.   

Abstract

BACKGROUND: The prognosis of patients with hepatocellular carcinoma (HCC) after curative resection varies greatly. Few studies had investigated the risk factors for early recurrence (recurrence-free time ≤ 1 year) of hepatitis B virus (HBV)-related HCCs meeting Milan criteria.
METHODS: A retrospective analysis was performed on the 224 patients with HCC meeting Milan criteria who underwent curative liver resection in our center between February 2007 and March 2012. The overall survival (OS) rate, recurrence-free survival (RFS) rate and risk factors for early recurrence were analyzed.
RESULTS: After a median follow-up of 33.3 months, HCC reoccurred in 105 of 224 patients and 32 died during the period. The 1-, 3- and 5-year OS rates were 97.3%, 81.6% and 75.6% respectively, and the 1-, 3- and 5-year RFS rates were 73.2%, 53.7% and 41.6%. Cox regression showed alpha-fetoprotein (AFP) > 800 ng/ml (HR 2.538, 95% CI 1.464-4.401, P=0.001), multiple tumors (HR 2.286, 95% CI 1.123-4.246, P=0.009) and microvascular invasion (HR 2.518, 95% CI 1.475-4.298, P=0.001) to be associated with early recurrence (recurrence-free time ≤ 1-year) of HCC meeting Milan criteria.
CONCLUSIONS: AFP > 800 ng/ml, multiple tumors and microvascular invasion are independent risk factors affecting early postoperative recurrence of HCC. In addition resection appears capable of replacing liver transplantation in some situations with safety and a better outcome.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24460258     DOI: 10.7314/apjcp.2013.14.12.7101

Source DB:  PubMed          Journal:  Asian Pac J Cancer Prev        ISSN: 1513-7368


  12 in total

1.  Preoperative Predictors Including the Role of Inflammatory Indices in Predicting Early Recurrence After Re-resection for Recurrent Hepatocellular Carcinoma.

Authors:  Yuxin Guo; Darren W Chua; Ye-Xin Koh; Ser-Yee Lee; Peng-Chung Cheow; Juinn-Huar Kam; Jin-Yao Teo; Pierce K Chow; Alexander Y Chung; London L Ooi; Chung-Yip Chan; Brian K P Goh
Journal:  World J Surg       Date:  2019-10       Impact factor: 3.352

2.  Risk Factors for Early Recurrence of Single Lesion Hepatocellular Carcinoma After Curative Resection.

Authors:  Mitsugi Shimoda; Kazuma Tago; Takayuki Shiraki; Shozo Mori; Masato Kato; Taku Aoki; Keiichi Kubota
Journal:  World J Surg       Date:  2016-10       Impact factor: 3.352

Review 3.  Multidisciplinary management of recurrent and metastatic hepatocellular carcinoma after resection: an international expert consensus.

Authors:  Tianfu Wen; Chen Jin; Antonio Facciorusso; Matteo Donadon; Ho-Seong Han; Yilei Mao; Chaoliu Dai; Shuqun Cheng; Bixiang Zhang; Baogang Peng; Shunda Du; Changjun Jia; Feng Xu; Jie Shi; Juxian Sun; Peng Zhu; Satoshi Nara; J Michael Millis
Journal:  Hepatobiliary Surg Nutr       Date:  2018-10       Impact factor: 7.293

4.  Utility and Limitation of Preoperative Neutrophil Lymphocyte Ratio as a Prognostic Factor in Hepatocellular Carcinoma.

Authors:  Ei Uchinaka; Masataka Amisaki; Masaki Morimoto; Naruo Tokuyasu; Teruhisa Sakamoto; Soichiro Honjo; Hiroaki Saito; Yoshiyuki Fujiwara
Journal:  Yonago Acta Med       Date:  2018-12-27       Impact factor: 1.641

5.  High Levels of Gamma-Glutamyl Transferase and Indocyanine Green Retention Rate at 15 min as Preoperative Predictors of Tumor Recurrence in Patients With Hepatocellular Carcinoma.

Authors:  Peipei Song; Yoshinori Inagaki; Zhigang Wang; Kiyoshi Hasegawa; Yoshihiro Sakamoto; Junichi Arita; Wei Tang; Norihiro Kokudo
Journal:  Medicine (Baltimore)       Date:  2015-05       Impact factor: 1.889

6.  Effects of various interventions on the occurrence of macrovascular invasion of hepatocellular carcinoma after the baseline serum γ-glutamyltransferase stratification.

Authors:  Yao Liu; Qun Zhang; Xue Yang; Yuxin Li; Bingbing Zhu; Shuaishuai Niu; Yunyi Huang; Ying Hu; Xianbo Wang
Journal:  Onco Targets Ther       Date:  2019-02-28       Impact factor: 4.147

7.  The Prediction of Survival in Hepatocellular Carcinoma Based on A Four Long Non-coding RNAs Expression Signature.

Authors:  Zongxing Yang; Yuhan Yang; Gang Zhou; Yan Luo; Wenjun Yang; Youliang Zhou; Jin Yang
Journal:  J Cancer       Date:  2020-04-12       Impact factor: 4.207

8.  Elevated Preoperative Serum Gamma-glutamyltranspeptidase Predicts Poor Prognosis for Hepatocellular Carcinoma after Liver Transplantation.

Authors:  Shun-Jun Fu; Qiang Zhao; Fei Ji; Mao-Gen Chen; Lin-Wei Wu; Qing-Qi Ren; Zhi-Yong Guo; Xiao-Shun He
Journal:  Sci Rep       Date:  2016-07-06       Impact factor: 4.379

9.  Prediction of early recurrence of hepatocellular carcinoma within the Milan criteria after radical resection.

Authors:  Jiliang Feng; Junmei Chen; Ruidong Zhu; Lu Yu; Yan Zhang; Dezhao Feng; Heli Kong; Chenzhao Song; Hui Xia; Jushan Wu; Dawei Zhao
Journal:  Oncotarget       Date:  2017-06-28

10.  Prognostic factors in patients with HBV-related hepatocellular carcinoma following hepatic resection.

Authors:  Narongsak Rungsakulkij; Wikran Suragul; Somkit Mingphruedhi; Pongsatorn Tangtawee; Paramin Muangkaew; Suraida Aeesoa
Journal:  Infect Agent Cancer       Date:  2018-06-08       Impact factor: 2.965

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.